
Overview
Consumer products maker's Q4 2025 revenue rose 29.2%, slightly beating analyst expectations
Adjusted EPS for Q4 2025 beat analyst expectations
Modern Oral net sales increased 266% yr/yr, accounting for 34% of total sales
Outlook
Turning Point expects 2026 Modern Oral gross revenue of $220-$240 mln and Net Revenue of $180-$190 million
Company anticipates Q1 2026 adjusted EBITDA of $24-$27 mln
Result Drivers
MODERN ORAL GROWTH - Modern Oral net sales surged 266% to $41.3 mln, making up 34% of total sales, driven by strong performance of FRE and ALP brands
STOKER'S SEGMENT GROWTH - Stoker's segment net sales rose 69.5%, driven by triple-digit growth in Modern Oral sales and single-digit growth in legacy products
ZIG-ZAG DECLINE - Zig-Zag segment net sales fell 12.8% due to planned wind-down of Clipper business and resource reallocation
Company press release: ID:nBw583W7ba
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Sales | Slight Beat* | $121.01 mln | $120.26 mln (4 Analysts) |
Q4 Adjusted EPS | Beat | $0.95 | $0.88 (3 Analysts) |
Q4 Net Income |
| $11.64 mln |
|
Q4 Gross Profit |
| $67.65 mln |
|
Q4 Operating income |
| $19.93 mln |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the tobacco peer group is "buy"
Wall Street's median 12-month price target for Turning Point Brands Inc is $122.50, about 10.6% below its February 27 closing price of $136.99
The stock recently traded at 33 times the next 12-month earnings vs. a P/E of 24 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.